Private medical detox for Lantana — 18 minutes, then straight into treatment.

RECO Island sits 18 minutes south of Lantana via Federal Highway — the closest small-census, physician-led medical detox for residents of Hypoluxo Island, Manalapan, Ocean Ridge, and Old Town Lantana. Withdrawal is scored on CIWA-Ar and COWS and treated with symptom-triggered protocols rather than fixed-schedule dosing. Detox transitions directly into residential care within the same organization, with the same primary therapist assignment continuing on day one — no third-party handoff, no waitlist gap, no clinical information lost between providers.

Lantana and Hypoluxo Island occupy a quiet strip of coast between Delray Beach and West Palm Beach, and for residents of these barrier-island communities the nearest physician-led medical detoxification unit is 18 minutes south on Federal Highway. RECO Island operates a small-census, nurse-staffed 24/7 detoxification setting in Delray Beach that treats alcohol, benzodiazepine, opioid, and polysubstance withdrawal on validated protocols, followed by direct in-house transition to residential treatment. This page describes what medical detox involves, when it is clinically indicated, and how admissions work from Lantana, Manalapan, Ocean Ridge, and Old Town Lantana.

When medical detox is the clinical indication

Medical detoxification is the medically supervised management of acute withdrawal from a psychoactive substance. It is indicated when withdrawal risk is moderate to severe: alcohol use disorder involving regular heavy consumption, benzodiazepine dependence at therapeutic or supratherapeutic doses, opioid use disorder with daily use, and polysubstance use combining any of the above. Alcohol and benzodiazepine withdrawal are the two categories in which medically unsupervised detox carries real mortality risk — withdrawal seizures, delirium tremens, and autonomic instability are not rare events at higher use levels. Opioid withdrawal is rarely fatal in medically healthy adults but is severe enough that untreated withdrawal is a leading driver of same-week relapse and overdose.

Level-of-care decisions at intake follow the ASAM Criteria across all six dimensions: acute intoxication and withdrawal potential, biomedical conditions and complications, emotional/behavioral/cognitive conditions, readiness to change, relapse/continued use potential, and recovery environment. A structured clinical review at admission distinguishes clients who require inpatient withdrawal management (ASAM 3.7-WM or 4-WM) from those who can be safely managed at lower intensities. Stimulant-only detox — cocaine or methamphetamine without co-occurring substance use — rarely meets medical necessity for inpatient withdrawal management, though supervised support during stimulant withdrawal has clinical value for sleep restoration, safety monitoring, and rapid entry into treatment.

Symptom-triggered protocols using validated withdrawal scales

The Clinical Institute Withdrawal Assessment for Alcohol, revised (CIWA-Ar) is a ten-item scale scored at defined intervals by trained nursing. Domains include nausea and vomiting, tremor, paroxysmal sweats, anxiety, agitation, tactile disturbances, auditory disturbances, visual disturbances, headache, and orientation. Medication — typically a long-acting benzodiazepine such as chlordiazepoxide or diazepam, or lorazepam in the setting of hepatic impairment — is administered when the CIWA-Ar score crosses treatment threshold rather than on a fixed clock schedule. Phenobarbital and gabapentin adjuncts are used in specific clinical scenarios where benzodiazepine tolerance is high or contraindicated.

The Clinical Opiate Withdrawal Scale (COWS) performs the same function for opioid withdrawal, scoring pulse rate, sweating, restlessness, pupil size, bone or joint aches, rhinorrhea and lacrimation, GI upset, tremor, yawning, anxiety, and gooseflesh skin. Buprenorphine induction is initiated when the COWS score reflects sufficient withdrawal to avoid precipitated withdrawal, typically at or above a score of 12. Clonidine and adjunctive comfort medications address autonomic and symptomatic complaints during the induction window. For clients who are candidates, naltrexone is discussed as a maintenance option after the acute detox course is complete.

Symptom-triggered dosing has been the standard of care for more than two decades because it reduces total medication exposure, shortens the average detox course, and produces cleaner clinical trajectories than fixed-schedule regimens. Running the scales actually requires nursing trained specifically in them and staffing ratios sufficient to score at bedside on interval — protocol on paper is not protocol in practice.

Medical evaluation and comorbidity management

Every admission to medical detox at RECO Island begins with a full medical evaluation: focused history and physical, laboratory workup including CBC, comprehensive metabolic panel, liver function tests, TSH, urine drug screen, urine pregnancy where indicated, and EKG where cardiovascular risk warrants it. Medication reconciliation covers not only current prescriptions but supplements, over-the-counter agents, and any medications the client has been managing outside of prescriber oversight. Depression and anxiety screening with the PHQ-9 and GAD-7 is completed once the client is oriented and stable enough for accurate self-report.

Chronic medical conditions are managed concurrently with withdrawal rather than deferred. Hypertension is often unmasked during alcohol withdrawal and treated actively; type 2 diabetes, hepatitis C, atrial fibrillation, seizure disorders, and post-surgical pain regimens all require continuous management. Psychiatric medications on which the client was already stabilized — sertraline, aripiprazole, lithium, quetiapine, olanzapine, buspirone — are continued unless there is a specific pharmacological reason to hold. Nutritional repletion, IV fluids where clinically indicated, and thiamine/folate/multivitamin protocols are standard for alcohol admissions.

Detoxification is a medical procedure. The staffing model — 24/7 registered nursing, on-call medical director, on-site psychiatric coverage — reflects that fact.

The transition into residential or PHP without gaps

The single most consequential clinical moment in a detox admission is the day the client transitions to the next level of care. Relapse and readmission data consistently show that gaps between detox discharge and the next admission — even 24 to 72 hours — sharply increase the probability of relapse, missed appointments, and disengagement from treatment. A well-run detox that discharges a client into an unscheduled follow-up is not a well-run detox.

At RECO Island the handoff from medical detox into residential treatment occurs within the same organization. The primary therapist assigned during residential care is introduced during detox. The treatment plan drafted in detox is the plan that continues on day one of residential — not a new plan negotiated at a new intake. Medical records, medication regimens, and clinical impressions do not have to be re-transmitted between organizations because there is no second organization. Family contact information, release-of-information paperwork, and post-detox scheduling are completed before discharge from the detox unit.

The transition is scheduled at admission, not negotiated on day five.

What to expect on the first day from Lantana

Admission from Lantana typically begins with a phone assessment: substance use history, last use, quantities, prior detox history, current medications, medical and psychiatric history, and insurance verification. When medical detox is clinically indicated and a bed is available, transport is arranged the same day where possible. The drive from Lantana to RECO Island’s Delray Beach location is roughly 11 miles and 18 minutes via Federal Highway; residents of Hypoluxo Island, Manalapan, Ocean Ridge, and Old Town Lantana all fall within the same window.

On arrival, clients meet the admitting nurse, complete lab draws, receive a medical evaluation, and are started on the appropriate withdrawal protocol. Personal belongings are inventoried and secured. First-day contact with a designated family member is supported under a signed release-of-information. Sleep, hydration, and nutrition are treated as first-day clinical priorities, not afterthoughts to be addressed once the client feels better.

Insurance and admissions from Lantana

RECO Island is in-network with, or negotiates single-case agreement pathways for, the major commercial carriers serving Palm Beach County: Florida Blue, BCBS, Aetna, Cigna, UnitedHealthcare, and Humana. Verification of benefits is completed at intake and communicated in writing before admission. Prior authorization for inpatient withdrawal management is pursued the same day where clinical criteria are met.

For Lantana residents whose inpatient benefits do not extend to the medical necessity level required, the admissions team documents alternatives — outpatient withdrawal management where medically appropriate, or referral to a community resource where the client falls outside program scope. RECO Island does not admit clients into inpatient detox who do not meet inpatient medical necessity criteria; that determination is a clinical one, not a marketing one.

Serving residents of: Hypoluxo Island, Manalapan, Ocean Ridge, Old Town Lantana.